Offering new options for men and women with incontinence issues, the Functional & Reconstructive Urology (FRU) Section in the University of Colorado Department of Surgery is studying two new devices that offer alternatives to polypropylene mesh, pump-operated systems, and other surgical therapies for incontinence that have been in use for the past 30 years.
Brian J. Flynn, MD, professor of urology and director of functional and reconstructive urology at the CU School of Medicine, is the principal investigator of the Adjustable Continence Therapy (ACT) prospective pre-market clinical trial in women. Flynn is also an investigator of the post-market study of the device in men, called Prostate Adjustable Continence Therapy (ProACT). The latter was approved by the FDA in 2017.
We spoke with Flynn about the devices, what makes them unique, and how this innovative therapy can improve patients’ lives.